Mohammed Qatanani
Chief Tech/Sci/R&D Officer at SCHOLAR ROCK HOLDING CORPORATION
Net worth: 3 M $ as of 2024-03-30
Profile
Mohammed Qatanani is currently the Chief Scientific Officer at Scholar Rock Holding Corp.
He previously worked as the Director-Discovery Research at Alexion Pharmaceuticals, Inc. from 2015 to 2018 and as the Vice President-Program & Alliance Management at Dyne Therapeutics, Inc. from 2018 to 2021.
Dr. Qatanani completed his undergraduate and graduate degrees at the American University of Beirut and holds an MBA from Baylor College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-15 | 147,019 ( 0.19% ) | 3 M $ | 2024-03-30 |
Mohammed Qatanani active positions
| Companies | Position | Start |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Chief Tech/Sci/R&D Officer | 2022-08-31 |
Former positions of Mohammed Qatanani
| Companies | Position | End |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-08-31 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-12-31 |
Training of Mohammed Qatanani
| American University of Beirut | Graduate Degree |
| Baylor College of Medicine | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| DYNE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Mohammed Qatanani